Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis

References

• Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001;44(6):1237–47.
   PubMed Web of Science ®Google Scholar
• Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 2000;43(9):1916–26.
   PubMed Web of Science ®Google Scholar
• Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators prostaglandins and nitric oxide. Clin Orthop Relat Res. 2004;427(suppl):537–46.
   Google Scholar
• Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum. 2002;46(10):2648–57.
   PubMedGoogle Scholar
• Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest. 1997;99(7):1534–45.
   PubMed Web of Science ®Google Scholar
• Neuhold LA, Killar L, Zhao W, Sung ML, Warner L, Kulik J, et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest. 2001;107(1):35–44.
   PubMed Web of Science ®Google Scholar
• Gregoretti IV, Lee YM, Goodson HV. Molecular evolution of the histone deacetylase family: functional implications of phyloge-netic analysis. J Mol Biol. 2004;338(1):17–31.
   Google Scholar
• de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuil-enburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003;370(Pt 3):737–49.
   Google Scholar
• Bernstein BE, Tong JK, Schreiber SL. Genomewide studies of histone deacetylase function in yeast. Proc Natl Acad Sci USA. 2000;97(25):13708–13.
   PubMed Web of Science ®Google Scholar
• Mulholland NM, Soeth E, Smith CL. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation. Oncogene. 2003;22(31):4807–18.
   Google Scholar
• Nair AR, Boersma LJ, Schatz L, Chaudhry MA, Muschel RJ. Paradoxical effects of trichostatin A: inhibition of NF-Y-associ-ated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA. Cancer Lett. 2001;166(1):55–64.
   Google Scholar
• Pujuguet P, Radisky D, Levy D, Lacza C, Bissell MJ. Trichos-tatin A inhibits beta-casein expression in mammary epithelial cells. J Cell Biochem. 200083(4):660–70.
   Google Scholar
• Saunders N, Dicker A, Popa C, Jones S, Dahler A. Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res. 1999;59(2):399–404.
   Google Scholar
• Lin HY, Chen CS, Lin SP, Weng JR. Targeting histone deace-tylase in cancer therapy. Med Res Rev. 2006;26(4):397–413.
   PubMed Web of Science ®Google Scholar
• Villar-Garea A, Esteller M. Histone deacetylase inhibitors: understanding a new wave of anticancer agents. Int J Cancer. 2004;112(2):171–8.
   Google Scholar
• Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov. 2002;1(4):287–99.
   PubMed Web of Science ®Google Scholar
• Kortenhorst MS, Carducci MA, Shabbeer S. Acetylation and histone deacetylase inhibitors in cancer. Cell Oncol. 2006;28(5-6):191–222.
   Google Scholar
• Blanchard F, Chipoy C. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov Today. 2005;10(3):197–204.
   PubMed Web of Science ®Google Scholar
• Lin HS, Hu CY, Chan HY, Liew YY, Huang HP, Lepescheux L, et al. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol. 2007;150(7):862–72.
   PubMed Web of Science ®Google Scholar
• Nasu Y, Nishida K, Miyazawa S, Komiyama T, Kadota Y, Abe N, et al. Trichostatin A, a histone deacetylase inhibitor, sup-presses synovial inflammation and subsequent cartilage destruc-tion in a collagen antibody-induced arthritis mouse model. Osteoarthr Cartil. 2008;16(6):723–32.
   PubMed Web of Science ®Google Scholar
• Nishida K, Komiyama T, Miyazawa S, Shen ZN, Furumatsu T, Doi H, et al. Histone deacetylase inhibitor suppression of auto-antibody-mediated arthritis in mice via regulation of pl6INK4a and p21(WAF1/Cip 1) expression. Arthritis Rheum. 2004;50(10): 3365–76.
   PubMed Web of Science ®Google Scholar
• Young DA, Lakey RL, Pennington CJ, Jones D, Kevorkian L, Edwards DR, et al. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther. 2005;7(3):R503–12.
   Web of Science ®Google Scholar
• Chabane N, Zayed N, Afif H, Mfuna-Endam L, Benderdour M, Boileau C, et al. Histone deacetylase inhibitors suppress inter-leukin- beta-induced nitric oxide and prostaglandin E2 produc-tion in human chondrocytes. Osteoarthr Cartil. 2008;16(10): 1267–74.
   Google Scholar
• Thomas CM, Fuller CJ, Whittles CE, Sharif M. Chondrocyte death by apoptosis is associated with cartilage matrix degrada-tion. Osteoarthr Cartil. 2007;15(1):27–34.
   PubMed Web of Science ®Google Scholar
• Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol. 1995;146(1):75–85.
   PubMed Web of Science ®Google Scholar
• Otsuki S, Taniguchi N, Grogan SP, D'Lima D, Kinoshita M, Lotz M. Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage. Arthritis Res Ther. 2008;10(3):R61.
   Google Scholar
• Guilak F, Alexopoulos LG, Upton ML, Youn I, Choi JB, Cao L, et al. The pericellular matrix as a transducer of biomechanical and biochemical signals in articular cartilage. Ann N Y Acad Sci. 2006;1068:498–512.
   PubMed Web of Science ®Google Scholar
• Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532): 1074–80.
   PubMed Web of Science ®Google Scholar
• Urnov FD. Chromatin remodeling as a guide to transcriptional regulatory networks in mammals. J Cell Biochem. 2003;88(4): 684–94.
   PubMed Web of Science ®Google Scholar
• Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem. 1982;42(2):65–82.
   PubMed Web of Science ®Google Scholar
• Chang S, Pikaard CS. Transcript profiling in Arabidopsis reveals complex responses to global inhibition of DNA methylation and histone deacetylation. J Biol Chem. 2005;280(1):796–804.
   PubMed Web of Science ®Google Scholar
• Reid G, Metivier R, Lin CY, Denger S, Ibberson D, Ivacevic T, et al. Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. Oncogene. 2005;24(30:4894–907.
   PubMedGoogle Scholar
• Nawaz Z, Baniahmad C, Burris TP, Stillman DJ, O'Malley BW, Tsai MJ. The yeast 5IN3 gene product negatively regulates the activity of the human progesterone receptor and positively reg-ulates the activities of GALA- and the HAP! activator. Mol Gen Genet. 1994;245(6):724–33.
   Google Scholar
• Mariadason JM, Corner GA, Augenlicht LH. Genetic repro-gramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res. 2000;60(16):4561–72.
   Google Scholar
• Chambers AE, Banerjee S, Chaplin T, Dunne J, Debemardi S, Joel SP, et al. Histone acetylation-mediated regulation of genes in leukaemic cells. Eur J Cancer. 2003;39(8):1165–75.
   PubMed Web of Science ®Google Scholar
• Libby P, Aikawa M. New insights into plaque stabilisation by lipid lowering. Drugs. 1998;56\(suppl 1):9–13. (discussion 33).
   Google Scholar
• McCawley LJ, Matrisian LM. Matrix metalloproteinases: multi-functional contributors to tumor progression. Mol Med Today. 2000;6(4):149–56.
   PubMedGoogle Scholar
• Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest. 1996;97(3):761–8.
   Google Scholar
• Verdin E, Dequiedt F, Kasler HG. Class II histone deacetylases: versatile regulators. Trends Genet. 2003;19(5):286–93.
   Google Scholar
• Chang S, Young BD, Li S, Qi X, Richardson JA, Olson EN. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell. 2006;126(2):321–34.
   PubMed Web of Science ®Google Scholar
• Jensen ED, Schroeder TM, Bailey J, Gopalakrishnan R, We-stendorf JJ. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacety-lation-independent manner. J Bone Miner Res. 2008;23(3):361–72.
   Google Scholar
• Mengshol JA, Vincenti MP, Brinckerhoff CE. IL-1 induces col-lagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res. 2001;29(21): 4361–72.
   Google Scholar
• Wang X, Manner PA, Horner A, Shum L, Tuan RS, Nuckolls GH. Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthr Cartil. 2004;12(12):963–73.
   PubMed Web of Science ®Google Scholar
• Kawaguchi H. Endochondral ossification signals in cartilage degradation during osteoarthritis progression in experimental mouse models. Mol Cells. 2008;25(1):1–6.
   PubMed Web of Science ®Google Scholar
• Kamekura S, Kawasaki Y, Hoshi K, Shimoaka T, Chikuda H, Maruyama Z, et al. Contribution of runt-related transcription fac-tor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 2006;54(8):2462–70.
   PubMedGoogle Scholar
• Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science. 2001;291 (5507):1304–51.
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Malizos KN, Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic interven-tion. Ann Rheum Dis. 2007;66(12):1616–21.
   Google Scholar
• Yun K, Im SH. Transcriptional regulation of MMP13 by Lefl in chondrocytes. Biochem Biophys Res Commun. 2007;364(4): b1009–14.
   PubMed Web of Science ®Google Scholar
• Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brine-kerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: dif-ferential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 2000;43(4):801–11.
   Google Scholar
• Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M. Pro-longed activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature. 1989;337(6208):661–3.
   PubMed Web of Science ®Google Scholar
• Conca W, Kaplan PB, Krane SM. Increases in levels of procol-lagenase messenger RNA in cultured fibroblasts induced by human recombinant interleukin 1 beta or serum follow c-jun expression and are dependent on new protein synthesis. J Clin Invest. 1989;83(5):1753–7.
   Google Scholar
• Borden P, Solymar D, Sucharczuk A, Lindman B, Cannon P, Heller RA. Cytokine control of interstitial collagenase and col-lagenase-3 gene expression in human chondrocytes. J Biol Chem. 1996;271(38):23577–81.
   PubMed Web of Science ®Google Scholar
• Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibi-tors: biological actions and therapeutic opportunities. J Cell Sci. 2002;115(Pt 19):3719–27.
   Google Scholar